Bicocca Open Archive

Logo unimib boa
COLLEDAN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.796
AS - Asia 17.257
EU - Europa 12.599
SA - Sud America 2.931
Continente sconosciuto - Info sul continente non disponibili 1.477
AF - Africa 401
OC - Oceania 36
Totale 59.497
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.981
SG - Singapore 6.366
HK - Hong Kong 3.632
IT - Italia 3.574
RU - Federazione Russa 2.619
CA - Canada 2.525
VN - Vietnam 2.415
CN - Cina 2.272
BR - Brasile 2.239
IE - Irlanda 1.664
DE - Germania 1.111
SE - Svezia 1.053
FR - Francia 703
BD - Bangladesh 611
GB - Regno Unito 505
IN - India 388
UA - Ucraina 308
KR - Corea 299
AR - Argentina 280
FI - Finlandia 218
ID - Indonesia 197
IQ - Iraq 183
ES - Italia 176
NL - Olanda 157
TR - Turchia 151
ZA - Sudafrica 126
PK - Pakistan 111
EC - Ecuador 106
CO - Colombia 96
AT - Austria 94
SA - Arabia Saudita 93
MX - Messico 89
JP - Giappone 80
VE - Venezuela 70
CH - Svizzera 66
BE - Belgio 65
PH - Filippine 64
PL - Polonia 56
UZ - Uzbekistan 55
EG - Egitto 51
JM - Giamaica 47
KE - Kenya 45
MY - Malesia 45
DK - Danimarca 43
PY - Paraguay 41
CL - Cile 40
MA - Marocco 40
NP - Nepal 36
CR - Costa Rica 34
PE - Perù 33
AU - Australia 30
JO - Giordania 30
AE - Emirati Arabi Uniti 29
DZ - Algeria 29
PT - Portogallo 28
ET - Etiopia 26
TN - Tunisia 25
CZ - Repubblica Ceca 24
EU - Europa 23
AZ - Azerbaigian 22
RO - Romania 22
KZ - Kazakistan 21
HN - Honduras 19
LT - Lituania 19
PS - Palestinian Territory 19
UY - Uruguay 18
NI - Nicaragua 17
TT - Trinidad e Tobago 17
OM - Oman 16
DO - Repubblica Dominicana 15
IR - Iran 14
AL - Albania 13
IL - Israele 13
RS - Serbia 13
PA - Panama 12
SN - Senegal 12
TH - Thailandia 12
EE - Estonia 11
TW - Taiwan 11
LB - Libano 10
KW - Kuwait 9
LY - Libia 9
BG - Bulgaria 8
BH - Bahrain 8
GR - Grecia 8
GT - Guatemala 8
SV - El Salvador 8
BO - Bolivia 7
KG - Kirghizistan 7
SK - Slovacchia (Repubblica Slovacca) 7
XK - ???statistics.table.value.countryCode.XK??? 7
AO - Angola 6
BB - Barbados 6
CI - Costa d'Avorio 6
NZ - Nuova Zelanda 6
HU - Ungheria 5
LV - Lettonia 5
MU - Mauritius 5
NG - Nigeria 5
QA - Qatar 5
Totale 57.958
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.585
Singapore 3.274
Toronto 2.296
Ashburn 2.023
San Jose 1.642
Dublin 1.622
Ann Arbor 1.254
Milan 912
New York 880
Princeton 820
Council Bluffs 739
Ho Chi Minh City 717
Santa Clara 705
Fairfield 659
Chicago 655
Frankfurt am Main 634
Chandler 588
Hanoi 576
Dallas 550
The Dalles 545
Woodbridge 528
Houston 452
Los Angeles 411
Rome 398
Lawrence 385
Lauterbourg 378
Wilmington 363
Altamura 339
Moscow 302
Seattle 298
Seoul 278
Beijing 259
Hefei 229
Cambridge 210
Jacksonville 202
Buffalo 184
São Paulo 182
San Diego 150
Helsinki 139
Shanghai 128
Andover 117
Dearborn 112
Da Nang 108
Jakarta 100
Haiphong 93
Boston 92
Nuremberg 92
London 91
Columbus 85
Rio de Janeiro 84
Atlanta 81
Boardman 81
Orem 80
Munich 79
Figino 77
Turin 73
Baghdad 71
Salt Lake City 68
Phoenix 67
Naples 65
Guangzhou 64
Nanjing 63
Brooklyn 58
Hangzhou 57
Denver 55
Johannesburg 55
Tokyo 53
Philadelphia 52
Florence 51
Montreal 50
San Francisco 50
Brasília 49
Belo Horizonte 48
Biên Hòa 46
Bologna 46
Tashkent 46
Hải Dương 44
Miami 44
Curitiba 43
Vienna 41
Dhaka 40
Norwalk 40
Amsterdam 39
Brussels 39
Manchester 38
Riyadh 37
Lahore 36
Nairobi 36
Quito 36
Tampa 35
Chennai 34
Cleveland 34
Istanbul 33
Tukwila 33
Warsaw 33
Washington 33
Campinas 32
Changsha 31
Charlotte 31
Las Vegas 31
Totale 33.923
Salva come PNG Salva come JPEG
Nome #
A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation 787
Reply to: “Outcome of in situ split liver transplantation in Italy over the last 25 years: An alternative analysis and personal view” 513
Recipient hepatectomy technique may affect oncological outcomes of liver transplantation for hepatocellular carcinoma 511
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 482
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 416
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 408
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 400
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 398
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 379
Health related quality of life in chronic liver diseases 356
Health Related Quality of Life in the Major Liver Conditions 340
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 335
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 332
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 326
Multicentre evaluation of case volume in minimally invasive hepatectomy 315
Delaying surgery for patients with a previous SARS-CoV-2 infection 310
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 309
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 307
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 301
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 300
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 292
Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients 287
Reno-portal bypass for non tumorous portal vein thrombosis in adult liver transplantation 286
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 280
COVID-19: role of resilience on the psychological impact of lockdown in liver transplant transitional candidates and recipients COVID-19: ruolo della resilienza sull’impatto psicologico del lockdown nei candidati e nei riceventi del trapianto di fegato (adolescenti-giovani adulti) 278
The impact of the COVID-19 outbreak on liver transplantation programs in Northern Italy 278
The Role of Imaging in Portal Vein Thrombosis: From the Diagnosis to the Interventional Radiological Management 276
Technical and Clinical Outcomes of Laparoscopic–Laparotomic Hepatocellular Carcinoma Thermal Ablation with Microwave Technology: Case Series and Review of Literature 274
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 272
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 267
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 266
Treatment of hepatocellular carcinoma: A cost analysis of yttrium-90 transarterial radioembolization versus sorafenib 262
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list 260
Post-operative heparin reduces early venous thrombotic complications after orthotopic paediatric liver transplantation 260
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 259
Balancing donor and recipient risk factors in liver transplantation: The value of D-MELD with particular reference to HCV recipients 257
Biliary complications in pediatric liver transplantation: findings of percutaneous transhepatic cholangiography in a large single-center cohort 257
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: Results from a 7-year experience 253
Combined double lung-liver transplantation for cystic fibrosis without cardio-pulmonary by-pass. 252
Arterioportal fistulas (Apfs) in pediatric patients: Single center experience with interventional radiological versus conservative management and clinical outcomes 252
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs 251
Portal vein thrombosis and liver transplantation: management, matching, and outcomes: a retrospective multicenter cohort study 247
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study 247
Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry 247
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 244
Venous outflow obstruction in pediatric left lateral segment split liver transplantation 243
Current Endovascular Management of Arterial Complications After Pediatric Liver Transplantation in a Tertiary Center 240
Selective use of ex-situ machine perfusion after normothermic regional perfusion in liver transplantation from donation after circulatory death 238
Extended right split liver graft for primary transplantation in children and adults. 237
Nuclear expression of s100a4 calcium binding protein increases cholangiocarcinoma invasiveness and metastasization 237
Early detection of the graft failure after pediatric liver transplantation: a Bergamo experience 236
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 233
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria 230
Trapianto intestinale 230
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry 229
Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient 228
Living Donor Lung Transplantation After Hematopoietic Stem Cell Transplantation From the Same Donor: A Risk Worth Taking 217
Successful pre- and posttransplant sofosbuvir-based anti-hepatitis C virus treatment in persons living with human immunodeficiency virus infection 215
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool 212
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma 212
Extended criteria liver donation after circulatory death with prolonged warm ischemia: a pilot experience of normothermic regional perfusion and no subsequent ex-situ machine perfusion 212
Exploring auxiliary liver transplantation in the era of transplant oncology - A proposal for a new liver splitting program (ALERT-50) 208
Use of extended right grafts from in situ split livers in adult liver transplantation: a comparison with whole-liver transplants. 208
Full-right-full-left split liver transplantation: The retrospective analysis of an early multicenter experience including graft sharing 208
Improving Outcome of Selected Patients With Non-Resectable Hepatic Metastases From Colorectal Cancer With Liver Transplantation: A Prospective Parallel Trial (COLT trial) 204
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 202
Successful Lung Transplantation From a Donor With Previous Severe COVID-19 Pneumonia 200
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 200
Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus 198
Physiological reno-portal bypass in liver transplantation with non-tumorous portal vein thrombosis 196
Improving outcomes of in situ split liver transplantation in Italy over the last 25 years 196
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation 196
Very Early Introduction of Everolimus in De Novo Liver Transplantation: Results of a Multicenter, Prospective, Randomized Trial 194
Liver transplants in children: The 8 years experience in Bergamo 194
A prospective policy development to increase split-liver transplantation for 2 adult recipients: Results of a 12-year multicenter collaborative study 190
Correction to: Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry (Updates in Surgery, (2017), 69, 3, (271-283), 10.1007/s13304-017-0489-x) 189
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial 185
Early post-liver transplant surgical morbidity in HIV-infected recipients: risk factor for overall survival? A nationwide retrospective study 185
A matched pair analysis of multicenter longterm follow-up after split-liver transplantation with extended right grafts 184
A national mandatory-split liver policy: A report from the Italian experience 184
Liver transplantation for hepatocellular carcinoma: Bergamo experience 182
Location and allocation: inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe 182
Full-Left Full-Right Split Liver Transplantation 181
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using “on demand” Approach: A Single Center Experience 180
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using" on demand" Approach: A Single Center Experience 180
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 176
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 176
Transitional care in pediatric liver transplantation: do we need to structure a personalized program? 176
Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma 173
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 173
Evidence for biliary epithelial to mesenchymal transition in human cholangiocarcinoma 172
Indications and successes of intestinal transplantation in children in the 21st century: A retrospective cohort study 171
Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry 169
Identifying the Aetiology of Acute Liver Failure Is Crucial to Impact Positively on Outcome 169
B-Hepatitis and Liver-Transplantation 165
Pre-transplant alpha-fetoprotein > 25.5 and its dynamic on waitlist are predictors of HCC recurrence after liver transplantation for patients meeting milan criteria 165
Split-liver transplantation with pediatric donors: A multicenter experience 163
EVIDENCE FOR EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN CHOLANGIOCARCINOMA 163
2018 Annual Report of the European Liver Transplant Registry (ELTR) – 50-year evolution of liver transplantation 159
Patterns of hepatitis delta virus reinfection and disease in liver transplantation 159
Totale 25.233
Salva come PNG Salva come JPEG
Categoria #
all - tutte 253.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 253.653
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.215 0 0 0 585 183 192 63 206 90 969 155 772
2022/20234.576 815 1.320 379 209 212 860 54 183 248 84 148 64
2023/20244.548 76 98 164 160 682 1.142 894 139 549 66 78 500
2024/202511.943 647 1.854 488 490 1.059 272 500 338 1.693 1.843 923 1.836
2025/202625.120 2.585 1.831 1.771 2.120 1.973 1.183 3.220 1.223 1.760 1.818 3.244 2.392
2026/20275.366 936 1.197 2.709 524 0 0 0 0 0 0 0 0
Totale 59.497